Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Tobacco giant Altria said on Wednesday it had submitted Premarket Tobacco Product Applications (PMTAs) to the U.S. Food and Drug Administration for its on! Plus oral nicotine pouch products.

Altria seeks FDA marketing order for oral nicotine pouch products

RICHMOND, Va.--(BUSINESS WIRE)---- $MO #Altria--Altria Announces PMTA Submission for on! PLUS™ Nicotine Pouches.

Altria Announces PMTA Submission for on! PLUS™ Nicotine Pouches

British American Tobacco

Philip Morris

Starwood Property

Undervalued dividend stocks focused on rewarding shareholders with capital returns are a good investment choice for a frothy market. Philip Morris International and Starwood Property Trust are highlighted as strong picks in this article for high cash flow and steady dividends. PM excels in innovative tobacco products, while STWD benefits from a diversified commercial mortgage REIT portfolio and higher interest rates.

I'm Buying Cash Cows With Up To 10% Yield

Ares Capital

Highwoods Properties

Sinclair Inc

Ship Finance

Sixth Street Specialty Lending

Western Union

If you are looking for stocks with the highest yields, look no further! First, I would make it clear that the stocks in this list are not necessarily the ones with the “highest yields.

7 Stocks With the Highest (Sustainable) Dividend Yields in 2024

Altria Group is facing several challenges which are reflected in its rock-bottom valuation, but it has some core strengths which make the stock a Buy. The biggest issue is the secular decline in shipment volume of its smokeable products, which declined by a staggering 10 percentage points YoY in the recent quarter. However, the company is making up for these lost volumes with price increases, and the worst-case scenario for volume decline is also not too bad for the long-term EPS trajectory.

Altria: 8.5% Dividend Looks More Attractive In An Overheated Stock Market

Cigarette volumes keep declining, which is especially concerning given MO's recent inability to offset the negative volume effect with pricing power. The Company tries navigating the market with alternative product categories, and there's some positive news regarding that. However, the alternative product segments also face some headwinds (NJOY), or MO is yet to launch its first products (heated tobacco sticks).

Altria Group Is Not A Buy. Here's Why

Altria's (MO) NJOY obtains authorization from the U.S. Food and Drug Administration for menthol e-vapor products.

Altria's (MO) Smoke-Free Growth Underway With Latest FDA Nod

Pfizer

Verizon

24/7 Insights Dividend stocks can supply investors with a steady stream of passive income.

3 Undervalued Dividend Stocks to Buy in June

Dynatrace Inc

Fortis

The essence of stock investing is bargain hunting. Every single investor hopes to buy low and sell high.

Undervalued and Under $50: Medium Priced Bargains To Buy

If investors expect interest rates to hold until next year, they should consider dividend-yielding stocks like Altria (NYSE: MO), Bristol Myers, and Pfizer (NYSE: PFE), which offer reasonable values and attractive yields.

Investing for the Next 12 Months? Buy These

WASHINGTON — The Food and Drug Administration on Friday authorized the first menthol-flavored electronic cigarettes for adult smokers, acknowledging that vaping flavors can reduce the harms of traditional tobacco smoking.

FDA OKs first menthol e-cigarettes - citing potential to help adult smokers

RICHMOND, Va.--(BUSINESS WIRE)---- $MO--NJOY Receives First FDA Authorizations for Menthol E-Vapor Products.

NJOY Receives First FDA Authorizations for Menthol E-Vapor Products

The decision lends new credibility to vaping companies' longstanding claim that their products can help blunt the toll of smoking.

FDA OKs first menthol e-cigarettes, citing potential to help adult smokers

The FDA's authorization comes at a time when the government is reviewing a potential ban on menthol cigarettes.

FDA approves first menthol flavored e-cigarettes from Altria's NJOY

The U.S. Food and Drug Administration authorized four of Altria's menthol e-cigarettes for sale in the country on Friday, making them the first ever flavored vapes the agency has permitted on the market.

In a first, FDA authorizes flavored e-cigarettes from Altria's NJOY for sale in the US

Altria distributes a generous dividend that yields 8.75% at the current share price. Its declining revenues could become a long-term threat to the sustainability of the payout.

Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Altria Stock

Turning Point Brands

Vector Group

Tobacco stocks have a bad reputation. Investors with a particular set of ethics tend to veer away from them because the companies' products are known to be detrimental to people's health.

3 Overlooked Tobacco Stocks Quietly Making Investors Rich

In the most recent trading session, Altria (MO) closed at $44.80, indicating a +0.22% shift from the previous trading day.

Altria (MO) Increases Yet Falls Behind Market: What Investors Need to Know

Nordic American Tankers

When building a retirement portfolio, focusing on the best high-yield dividend stocks to buy can result in better long-term outcomes than timing the market. That's because when a company offers both a high dividend yield and performs well year-over-year, the value of an investor's position can compound rapidly.

3 High-Yield Heavyweights to Anchor Your Portfolio for the Long Haul

Hess Midstream Partners

Lazard

NorthWestern

Dividend growth stocks can provide reliable cash flows and drive long-term wealth for income investors. Every month we screen for dividend stocks based on safety, growth, and consistency metrics to help identify worthwhile investments. This month we have five familiar names, but one utility name we haven't touched on in over two years now, which appears to be an attractive consideration.

June's 5 Dividend Growth Stocks With 5.02%+ Yields

Altria Group stock has performed reasonably well recently. Altria needs to execute its smokeless transition well to lift its well-battered valuation further. Structural headwinds on its legacy tobacco segment are likely priced into its attractive valuation.

Altria: Unwarranted Pessimism With A 9% Yield

Cronos Group

Marlboro-maker Altria has been exploring ways to diversify beyond tobacco for decades. Despite its early stumbles in cannabis, the tobacco giant still stands as one of the most compelling investing vehicles in the industry.

Here Is the Best Cannabis Stock to Buy Now

Bristol-Myers

Dominion Energy

Kenvue

Rio Tinto plc Sponsored

24/7 Insights Quality dividend stocks can generate solid total returns and yield passive income.

6 of Wall Street's Favorite High-Yield Blue Chip Dividend Stocks to Buy in June

Diversified investors have not been rewarded so far in 2024 as the tech-heavy SPX has outperformed value strategies and the total return of defensive sectors. But Altria presents solid fundamentals with high free cash flow, steady EPS growth, and an attractive dividend yield. Altria's technical view has improved with resistance at $47-$49, support at 200-day moving average following a break of a multi-year downtrend.

Altria: A Near-9% Yield With Buybacks, Bulls Break The Downtrend

Smoking causes cardiovascular diseases, even with minimal cigarette consumption. Nonetheless, its production has played a major role in America's history. Since 2005 Altria's stock performance has outperformed the S&P 500 but has stagnated since 2017. Altria's strategic shift towards e-vapor products and strong dividends make it a compelling option for income-focused investors.

News for Altria Stock (MO)